These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 27754363)

  • 1. Mutagenic Effects of Ribavirin on Hepatitis E Virus-Viral Extinction versus Selection of Fitness-Enhancing Mutations.
    Todt D; Walter S; Brown RJ; Steinmann E
    Viruses; 2016 Oct; 8(10):. PubMed ID: 27754363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribavirin Treatment Failure-Associated Mutation, Y1320H, in the RNA-Dependent RNA Polymerase of Genotype 3 Hepatitis E Virus (HEV) Enhances Virus Replication in a Rabbit HEV Infection Model.
    Wang B; Mahsoub HM; Li W; Heffron CL; Tian D; Hassebroek AM; LeRoith T; Meng XJ
    mBio; 2023 Apr; 14(2):e0337222. PubMed ID: 36809085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome.
    Todt D; Gisa A; Radonic A; Nitsche A; Behrendt P; Suneetha PV; Pischke S; Bremer B; Brown RJ; Manns MP; Cornberg M; Bock CT; Steinmann E; Wedemeyer H
    Gut; 2016 Oct; 65(10):1733-43. PubMed ID: 27222534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis E virus treatment and ribavirin therapy: viral mechanisms of nonresponse.
    Todt D; Meister TL; Steinmann E
    Curr Opin Virol; 2018 Oct; 32():80-87. PubMed ID: 30384328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients.
    Debing Y; Gisa A; Dallmeier K; Pischke S; Bremer B; Manns M; Wedemeyer H; Suneetha PV; Neyts J
    Gastroenterology; 2014 Nov; 147(5):1008-11.e7; quiz e15-6. PubMed ID: 25181691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
    Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose sofosbuvir and sofosbuvir-plus-ribavirin therapy inhibit Hepatitis E Virus (HEV) replication in a rabbit model for acute HEV infection.
    Liang Z; Shu J; He Q; Zhang F; Dai L; Wang L; Lu F; Wang L
    Antiviral Res; 2022 Mar; 199():105274. PubMed ID: 35247472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.
    Todt D; Moeller N; Praditya D; Kinast V; Friesland M; Engelmann M; Verhoye L; Sayed IM; Behrendt P; Dao Thi VL; Meuleman P; Steinmann E
    Antiviral Res; 2018 Sep; 157():151-158. PubMed ID: 30036559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling of Hepatitis E virus RNA-dependent RNA polymerase genotype 3 from a chronic patient and
    Cancela F; Rendon-Marin S; Quintero-Gil C; Houston DR; Gumbis G; Panzera Y; Pérez R; Arbiza J; Mirazo S
    J Biomol Struct Dyn; 2023 Feb; 41(2):705-721. PubMed ID: 34861797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral candidates against the hepatitis E virus (HEV) and their combinations inhibit HEV growth in in vitro.
    Nishiyama T; Kobayashi T; Jirintai S; Nagashima S; Primadharsini PP; Nishizawa T; Okamoto H
    Antiviral Res; 2019 Oct; 170():104570. PubMed ID: 31362004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of virus‒host recombinant variants of the hepatitis E virus.
    Paronetto O; Allioux C; Diméglio C; Lobjois L; Jeanne N; Ranger N; Boineau J; Pucelle M; Demmou S; Abravanel F; Chapuy-Regaud S; Izopet J; Lhomme S
    J Virol; 2024 Jun; 98(6):e0029524. PubMed ID: 38712945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Counteracting quasispecies adaptability: extinction of a ribavirin-resistant virus mutant by an alternative mutagenic treatment.
    Perales C; Agudo R; Domingo E
    PLoS One; 2009; 4(5):e5554. PubMed ID: 19436746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-Host HEV Quasispecies Evolution Shows the Limits of Mutagenic Antiviral Treatments.
    Colomer-Castell S; Gregori J; Garcia-Cehic D; Riveiro-Barciela M; Buti M; Rando-Segura A; Vico-Romero J; Campos C; Ibañez-Lligoña M; Adombi CM; Cortese MF; Tabernero D; Esteban JI; Rodriguez-Frias F; Quer J
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation in the Hepatitis E Virus Polymerase and Outcome of Ribavirin Therapy.
    Lhomme S; Kamar N; Nicot F; Ducos J; Bismuth M; Garrigue V; Petitjean-Lecherbonnier J; Ollivier I; Alessandri-Gradt E; Goria O; Barth H; Perrin P; Saune K; Dubois M; Carcenac R; Lefebvre C; Jeanne N; Abravanel F; Izopet J
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1608-14. PubMed ID: 26711757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
    Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
    Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic determinants of host- and virus-derived insertions for hepatitis E virus replication.
    Wißing MH; Meister TL; Nocke MK; Gömer A; Masovic M; Knegendorf L; Brüggemann Y; Bader V; Siddharta A; Bock CT; Ploss A; Kenney SP; Winklhofer KF; Behrendt P; Wedemeyer H; Steinmann E; Todt D
    Nat Commun; 2024 Jun; 15(1):4855. PubMed ID: 38844458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122.
    Haldipur B; Bhukya PL; Arankalle V; Lole K
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin.
    Lhomme S; DebRoy S; Kamar N; Abravanel F; Metsu D; Marion O; Dimeglio C; Cotler SJ; Izopet J; Dahari H
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31323954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hepatitis E virus.
    Dalton HR; Kamar N
    Curr Opin Infect Dis; 2016 Dec; 29(6):639-644. PubMed ID: 27607911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribavirin-induced mutagenesis across the complete open reading frame of hepatitis C virus genotypes 1a and 3a.
    Mejer N; Fahnøe U; Galli A; Ramirez S; Benfield T; Bukh J
    J Gen Virol; 2018 Aug; 99(8):1066-1077. PubMed ID: 29927371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.